Literature DB >> 22028222

Molecular combing reveals allelic combinations in facioscapulohumeral dystrophy.

Karine Nguyen1, Pierre Walrafen, Rafaëlle Bernard, Shahram Attarian, Charlène Chaix, Catherine Vovan, Emilie Renard, Nathalie Dufrane, Jean Pouget, Anne Vannier, Aaron Bensimon, Nicolas Lévy.   

Abstract

OBJECTIVE: The genetic variation underlying facioscapulohumeral muscular dystrophy (FSHD), 1 of the most common hereditary neuromuscular disorders, is complex, and associated with the contraction of a repeat array (D4Z4) at the subtelomeric end of chromosome 4q. Nonpathogenic variants of 4q and the presence of a homologous array on chromosome 10q make FSHD diagnosis extremely challenging, at least in individuals with nonstandard D4Z4 arrays. We aimed to improve FSHD molecular analysis by proposing an alternative technique to the Southern blot.
METHODS: We applied molecular combing (MC) to directly visualize allelic combinations associated with FSHD.
RESULTS: MC enabled the accurate diagnosis of 32 FSHD patients. Unreported haplotypes and rearrangements, as well as somatic mosaicism, which is common in the 10 to 30% of cases that are sporadic, were detectable by MC.
INTERPRETATION: MC enables the detailed exploration of the FSHD locus and accurate diagnosis of FSHD, the first Mendelian disease to benefit from this technique. MC is also likely to be applicable to other copy number-variant or repeat expansion-associated human diseases.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Year:  2011        PMID: 22028222     DOI: 10.1002/ana.22513

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  15 in total

Review 1.  Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?

Authors:  Mark Richards; Frédérique Coppée; Nick Thomas; Alexandra Belayew; Meena Upadhyaya
Journal:  Hum Genet       Date:  2011-10-09       Impact factor: 4.132

2.  Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity.

Authors:  Sabrina Sacconi; Pilar Camaño; Jessica C de Greef; Richard J L F Lemmers; Leonardo Salviati; Pascal Boileau; Adolfo Lopez de Munain Arregui; Silvère M van der Maarel; Claude Desnuelle
Journal:  J Med Genet       Date:  2011-10-07       Impact factor: 6.318

Review 3.  Deciphering transcription dysregulation in FSH muscular dystrophy.

Authors:  Melanie Ehrlich; Michelle Lacey
Journal:  J Hum Genet       Date:  2012-06-21       Impact factor: 3.172

4.  High-resolution breakpoint junction mapping of proximally extended D4Z4 deletions in FSHD1 reveals evidence for a founder effect.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; David San Leon Granado; Nienke van der Stoep; Henk Buermans; Robin van Schendel; Joost Schimmel; Marianne de Visser; Rudy van Coster; Marc Jeanpierre; Pascal Laforet; Meena Upadhyaya; Baziel van Engelen; Sabrina Sacconi; Rabi Tawil; Nicol C Voermans; Mark Rogers; Silvère M van der Maarel
Journal:  Hum Mol Genet       Date:  2022-03-03       Impact factor: 5.121

5.  Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy.

Authors:  Nathalie Caruso; Balàzs Herberth; Marc Bartoli; Francesca Puppo; Julie Dumonceaux; Angela Zimmermann; Simon Denadai; Marie Lebossé; Stephane Roche; Linda Geng; Frederique Magdinier; Shahram Attarian; Rafaelle Bernard; Flavio Maina; Nicolas Levy; Françoise Helmbacher
Journal:  PLoS Genet       Date:  2013-06-13       Impact factor: 5.917

6.  Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.

Authors:  Takako I Jones; Oliver D King; Charis L Himeda; Sachiko Homma; Jennifer C J Chen; Mary Lou Beermann; Chi Yan; Charles P Emerson; Jeffrey B Miller; Kathryn R Wagner; Peter L Jones
Journal:  Clin Epigenetics       Date:  2015-03-29       Impact factor: 6.551

7.  Combing of genomic DNA from droplets containing picograms of material.

Authors:  Jochem Deen; Wouter Sempels; Raf De Dier; Jan Vermant; Peter Dedecker; Johan Hofkens; Robert K Neely
Journal:  ACS Nano       Date:  2015-01-08       Impact factor: 15.881

8.  Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.

Authors:  Takako I Jones; Chi Yan; Peter C Sapp; Diane McKenna-Yasek; Peter B Kang; Colin Quinn; Johnny S Salameh; Oliver D King; Peter L Jones
Journal:  Clin Epigenetics       Date:  2014-10-29       Impact factor: 6.551

9.  Segregation between SMCHD1 mutation, D4Z4 hypomethylation and Facio-Scapulo-Humeral Dystrophy: a case report.

Authors:  Marie-Cécile Gaillard; Francesca Puppo; Stéphane Roche; Camille Dion; Emmanuelle Salort Campana; Virginie Mariot; Charlene Chaix; Catherine Vovan; Killian Mazaleyrat; Armand Tasmadjian; Rafaelle Bernard; Julie Dumonceaux; Shahram Attarian; Nicolas Lévy; Karine Nguyen; Frédérique Magdinier; Marc Bartoli
Journal:  BMC Med Genet       Date:  2016-09-15       Impact factor: 2.103

10.  FSHD1 Diagnosis in a Russian Population Using a qPCR-Based Approach.

Authors:  Nikolay Vladimirovich Zernov; Anna Alekseevna Guskova; Mikhail Yurevich Skoblov
Journal:  Diagnostics (Basel)       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.